Oric Pharmaceuticals Stock Quote ORIC - Stock Price, News, Charts, Message Board, Trades

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Oric Pharmaceuticals Inc (ORIC) Quote

Oric Pharmaceuticals Inc (ORIC)

7.69

0.17

(2.26%)

At close: July 05 4:00PM

Delayed by 15 minutes

7.69

0.01

( 0.13% )

After Hours: 4:07PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

7.69

Bid

7.45

Ask

7.80

Volume

333,704

7.32 Day's Range 7.80

5.27 52 Week Range 16.65

Market Cap

Previous Close

7.52

Open

7.55

Last Trade

Last Trade Time

16:06:37

Financial Volume

$ 2,546,370

VWAP

7.6306

Average Volume (3m)

431,964

Shares Outstanding

67,422,307

Dividend Yield

-

PE Ratio

-5.14

Earnings Per Share (EPS)

-1.49

Revenue

-

Net Profit

-100.7M

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company h... ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101, ORIC-944, ORIC-114, and ORIC-533. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.oricpharma.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Oric Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ORIC. The last closing price for Oric Pharmaceuticals was $7.52. Over the last year, Oric Pharmaceuticals shares have traded in a share price range of $ 5.27 to $ 16.65.

Oric Pharmaceuticals currently has 67,422,307 shares outstanding. The market capitalization of Oric Pharmaceuticals is $507.02 million. Oric Pharmaceuticals has a price to earnings ratio (PE ratio) of -5.14.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, July 05, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that...

Form 8-K - Current report

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 07, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that...

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates

Initiated three ORIC-114 Phase 1b expansion cohorts in NSCLC patients with EGFR exon 20 insertion, HER2 exon 20 insertion, or EGFR atypical mutations; updated Phase 1b data expected in the first...

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO and SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.62	8.76944837341	7.07	7.87	6.94	401519	7.56769663	CS
4	-1.09	-12.4145785877	8.78	8.96	6.33	448455	7.38940193	CS
12	-2.21	-22.3232323232	9.9	10.15	6.33	431964	8.49281745	CS
26	-1.21	-13.595505618	8.9	16.65	6.33	514975	10.81514957	CS
52	-0.09	-1.15681233933	7.78	16.65	5.27	442712	9.3750114	CS
156	-11.83	-60.6045081967	19.52	26.7	2.36	403200	7.97170032	CS
260	-18.31	-70.4230769231	26	40.81	2.36	355373	11.85392927	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DYNTDynatronics Corp	$ 0.3186 (50.28%)	5.43M
SHPWShapeways Holdings Inc	$ 0.3101 (47.67%)	2.02M
IDYAIDEAYA Biosciences Inc	$ 40.99 (19.64%)	54.78k
LGHLWLion Group Holding Ltd	$ 0.009 (15.38%)	37.64k
DBGIDigital Brands Group Inc	$ 1.74 (14.78%)	3.04k
ABTSAbits Group Ltd	$ 0.40 (-16.95%)	22.86k
GTBPGT Biopharma Inc	$ 2.65 (-7.99%)	2k
ZCARZoomcar Holdings Inc	$ 0.174 (-7.50%)	191.7k
SMXSMX Security Matters Public Company	$ 0.125 (-7.41%)	1.25M
SDOTSadot Group Inc	$ 0.4005 (-6.67%)	1.4k
MAXNMaxeon Solar Technologies Ltd	$ 0.248 (3.33%)	22.3M
WBDWarner Brothers Discovery Inc	$ 7.20 (-0.14%)	6.16M
DYNTDynatronics Corp	$ 0.3186 (50.28%)	5.43M
NVDANVIDIA Corporation	$ 125.76 (-0.06%)	4.58M
SBUXStarbucks Corporation	$ 76.0099 (-0.05%)	3.07M

Monksdream

Monksdream 1 day ago

Monksdream

Monksdream 2 days ago

Monksdream

Monksdream 2 months ago

ORIC 10Q due 5/6

Monksdream

Monksdream 2 months ago

Monksdream

Monksdream 4 months ago

ORIC 10Q due 3/16

Monksdream

Monksdream 4 months ago

ORIC new 52 week high

Monksdream

Monksdream 4 months ago

ORIC new 52 week high

Monksdream

Monksdream 4 months ago

ORIC new 52 week high

Monksdream

Monksdream 5 months ago

ORIC new 52 weewk high

Monksdream

Monksdream 5 months ago

ORIC new 52 week high

TheFinalCD

TheFinalCD 2 years ago

$ORIC LOOKS LIKE $6 COMING

makinezmoney

makinezmoney 2 years ago

$ORIC: Tapped $5.40....... still got steam

It ain't over yet

GO $ORIC

DH112

DH112 2 years ago

Today is green fields

TheFinalCD

TheFinalCD 2 years ago

Pfizer will pay $4.65 per share for 5,376,344 of Oric's common shares, for a total of $25 million. The companies plan to move the treatment into a Phase 2 clinical trial in combination with elranatamab, Pfizer's investigational treatment of multiple myeloma

https://finance.yahoo.com/news/oric-pharmaceuticals-announces-clinical-development-224800151.html

makinezmoney

makinezmoney 2 years ago

$ORIC: 5.25 now........................... lets get to $10

I know you can do it babyyyyyyyyyyyyyyyyy

GO $ORIC

makinezmoney

makinezmoney 2 years ago

$ORIC : Now at 4.90

YESsssssssssssssss............ this is very impressive news with deal with Pfizer.

Me likes it

GO $ORIC

crudeoil24

crudeoil24 2 years ago

Shares of Oric Pharmaceuticals Inc. jumped nearly 60% to $4.79 in premarket trading Thursday after the company agreed to sell $25 million in shares to Pfizer Inc.

The clinical-stage oncology company said Wednesday evening that Pfizer has agreed to buy nearly 5.4 million shares of Oric's common stock for $4.65 apiece.

The investment is part of a clinical development collaboration between the two companies on a Phase 2 study examining Oric's ORIC-533 treatment for multiple myeloma, the companies said.

The companies said the collaboration would potentially advance the treatment into a combination study with Pfizer's elranatamab, an investigational treatment for multiple myeloma.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

December 22, 2022 07:25 ET (12:25 GMT)

makinezmoney

makinezmoney 2 years ago

$ORIC: BOOOoommmmmmm........... Pfiizer invests $25Milly in ORIC

Letssssssss goooooooooooooooooo.

Added 5k shares here at 4.30

Great NEWS

https://www.tipranks.com/news/oric-pharmaceuticals-nasdaqoric-stock-spikes-on-pfizer-deal

GO $ORIC

Oric Pharmaceuticals

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions